4th Quarter - Amendment
ALLERGAN, INC. for ALLERGAN, INC.
Firm
Client
Income
—
Expenses
$390,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 21, 2009 | $440,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jun 19, 2009 | $390,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
HR1424: EMERGENCY ECONOMIC STABILIZATION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Medicare/Medicaid MMM
HR5629: PATHWAY FOR BIOSIMILARS ACT; PROVISIONS OF FOLLOW-ON BIOLOGICALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.